John Bomalaski

Company: Polaris Pharmaceuticals

Job title: Executive Vice President, Medial Affairs

Seminars:

Sharing an Update From Polaris – ADI-PEG 20 in Glioblastoma: Preclinical Studies & Phase I-II Results 11:00 am

Review preclinical studies and phase I results Gain an update on phase II and phase II/III studies Discuss the initiation of ADI-PEG 20 into GBM agileRead more

day: Conference Day 1